Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

☰

Patient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-fda.jpg" NAME"Patient Deaths Prompt the FDA to Suspend Three of Merck's Keytruda Trials" ALT"Patient Deaths Prompt the FDA to Suspend Three of Merck's Keytruda Trials"July 6, 2017By Alex Keown,…

Continue ReadingPatient Deaths Prompt the FDA to Suspend Three of Merck & Co.'s Keytruda Trials

Biotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-celgene.jpg" NAME"Biotech Bestie Celgene Takes Stake, Inks $1 Billion Deal With BeiGene" ALT"Biotech Bestie Celgene Takes Stake, Inks $1 Billion Deal With BeiGene"July 6, 2017By Mark Terry, BioSpace.com Breaking…

Continue ReadingBiotech Bestie Celgene Takes Stake, Inks $1 Billion+ Deal With BeiGene

Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-stocks2.jpg" NAME"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug" ALT"Bay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug"July…

Continue ReadingBay Area's Coherus Dealt Another Blow as Daiichi Sankyo Discontinues Work on RA Drug

Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial" ALT"Bristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial"July 5, 2017By Mark Terry, BioSpace.com Breaking News... Source: BioSpace

Continue ReadingBristol-Myers Squibb's Opdivo Prevails in Phase III Melanoma Trial